Vice President QSP
Metrum Research Group, United States
Dr. Kirouac leads the Quantitative Systems Pharmacology department at Metrum Research Group, a global leader in biomedical modeling and simulation. Prior to joining Metrum, he built the data science department at a cell therapy start-up (Notch Therapeutics) which was acquired by Roche. He previously held scientific positions in large pharma (Genentech), mid-size biotech (Merrimack Pharmaceuticals), and consulting (Applied BioMath). He has been developing mathematical models of biological systems for over 20 years, co-authoring 29 scientific publications on dynamical systems modeling, bioinformatics, machine learning, drug development and cell therapy.
An engineer at heart, Dr. Kirouac did post-doctoral training at MIT and Harvard Medical School, holds a PhD in Biomedical Engineering from the University of Toronto, and Bachelors degrees in both Chemical Engineering and Genetics. He is an Adjunct Professor at the University of British Columbia School of BioMedical Engineering, formerly chaired the ASCPT Systems Pharmacology community, and a recipient of the 2019 CPT:PSP systems pharmacology award.
Disclosure information not submitted.
Applications and Challenges of MIDD in Nucleic Acid therapies
Sunday, October 19, 2025
11:00 AM - 12:30 PM MDT
Panel - Applications and Challenges of MIDD in Nucleic Acid therapies
Sunday, October 19, 2025
12:00 PM - 12:30 PM MDT